This most current twist within the Lykos Therapeutics saga threatens An important overhaul of the company’s strategy and direction, with Musk ally and billionaire investor Antonio Gracias showing up to desire to get the corporation back again toward its nonprofit drug progress roots and a more Doblinite philosophy.In lots of respects, the for-gai